Senate support of broad liability reform is lacking

Focus will likely shift to access issues and away from caps on damages,senators say

Related Content:

Practice Management
Urology Times Money Matters: Alternative Investments
What can be learned from CMS data on health care spending?
FDA finalizes blueprint for cancer drug trials involving patients with CNS metastases